PubRank
Search
About
Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor
Clinical Trial ID NCT03039205
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT03039205
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.
Ann Intern Med
1999
82.86
2
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
BMJ
2002
20.22
3
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
N Engl J Med
2009
18.03
4
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
N Engl J Med
2004
9.13
5
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis.
Ann Intern Med
2012
3.78
6
Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors.
J Am Coll Cardiol
2003
2.99
7
Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.
Circulation
2009
2.84
8
Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment.
Thromb Haemost
2008
2.46
9
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
J Am Coll Cardiol
2004
2.32
10
The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions.
J Am Coll Cardiol
2002
2.03
11
Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry.
Circulation
2010
2.02
12
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial.
Circulation
2010
1.96
13
Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes.
Circulation
2002
1.88
14
Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease.
J Am Coll Cardiol
2011
1.43
15
Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy.
J Am Coll Cardiol
2010
1.26
16
A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure.
Am J Cardiol
2009
0.94
17
Ticagrelor induces adenosine triphosphate release from human red blood cells.
Biochem Biophys Res Commun
2012
0.83
18
Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with severe renal impairment.
J Clin Pharmacol
2011
0.82
19
Ticagrelor in the renal dysfunction subgroup: subjugated or substantiated?
Circulation
2010
0.75
20
Antiplatelet agents for chronic kidney disease.
Cochrane Database Syst Rev
2022
0.75
Next 100